Please note, this OEL/ADE monograph also applies to ephedrine base (CAS RN 299-42-3), and ephedrine sulfate (CAS RN 134-72-5). Ephedrine is a mixed-acting oral sympathomimetic indicated for the treatment of asthma, drug induced low blood pressure, and the common cold. Ephedrine’s mechanism of action stems from stimulation of both alpha-adrenergic and betaadrenergic receptors. It exerts a direct effect on adrenergic receptors and an indirect action due to the release of norepinephrine. Ephedrine stimulates the central nervous system and increases blood pressure by vasoconstriction and increasing cardiac output. Stimulation of beta-adrenergic receptors in the lungs results in bronchodilation. Urinary retention occurs because of constriction of the sphincter muscle and relaxation of the urinary bladder wall. Pharmacologic actions of ephedrine include elevation of blood pressure, increased pulse rate, vasoconstriction and cardiac stimulation to increase output and force of contraction.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), and to obtain the following information:
To order an OEL/ADE monograph for Ephedrine Hydrochloride, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.